Ysios news
26.10.18
Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development
26.09.18
Minoryx Therapeutics raises €21.3M in Series B funding round
portfolio news
28.11.18
BioClin Therapeutics Announces Name Change to Rainier Therapeutics
30.10.18
Aura Biosciences Presents Updated Phase 1b/2 Clinical Data for AU-011 at the American Academy of Ophthalmology 2018 Annual Meeting
